Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Current Pharmaceutical Design|October 18, 2016
Polymeric Nanomaterials as Nanomembrane Entities for Biomolecule and Drug DeliveryAirama Albisa, Laura Espanol, Martin Prieto, et al.Journal of Ophthalmology|May 10, 2021
Weight of Different Intraocular Lenses: Evaluation of Toricity, Focality, Design, and MaterialÁngel López-Vázquez, Inés Contreras, Sergio Martin-Prieto, et al.Nanomedicine (London, England)|November 28, 2019
Triggered drug release from hybrid thermoresponsive nanoparticles using near infrared lightIsabel Ortiz de Solorzano, Martin Prieto, Gracia Mendoza, et al.Journal of Materials Chemistry. B|July 30, 2021
Chalcogenide nanoparticles and organic photosensitizers for synergetic antimicrobial photodynamic therapyCarlos Garin, Teresa Alejo, Vanesa Perez-Laguna, et al.Transplantation|September 19, 2007
Adherence to Lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hepatitis B virus recurrenceMaria Buti, Antoni Mas, Martin Prieto, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2003
Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?Marina Berenguer, Victoria Aguilera, Martin Prieto, et al.Transplantation|December 1, 2017
Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation StudyLorena Puchades, Stephanie Chau, John A Dodson, et al.Acta Biomaterialia|October 1, 2019
Gold nanoparticles for the in situ polymerization of near-infrared responsive hydrogels based on fibrinClara Escudero-Duch, Francisco Martin-Saavedra, Martin Prieto, et al.Annals of Transplantation|May 10, 2022
Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional StudyBruno Roche, Artur Bauhofer, Miguel Ãngel Gomez Bravo, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|July 11, 2006
Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allograftsJoan Figueras, Martin Prieto, Angel Bernardos, et al.Pageof 3